Marc Tessier-Lavigne - Mar 23, 2022 Form 4/A - Amendment Insider Report for Denali Therapeutics Inc. (DNLI)

Role
Director
Signature
/s/ Tyler Nielsen, by power of attorney
Stock symbol
DNLI
Transactions as of
Mar 23, 2022
Transactions value $
-$676,583
Form type
4/A - Amendment
Date filed
6/28/2022, 03:07 PM
Date Of Original Report
Mar 25, 2022
Previous filing
Mar 23, 2022
Next filing
Jun 6, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DNLI Common Stock Sale -$281K -8.4K -0.41% $33.40 2.04M Mar 23, 2022 Direct F1, F2, F3
transaction DNLI Common Stock Sale -$396K -11.6K -0.57% $34.14 2.02M Mar 23, 2022 Direct F1, F3, F4
holding DNLI Common Stock 78.8K Mar 23, 2022 The Tessier-Lavigne/Hynes Irrevocable Trust 1 F5
holding DNLI Common Stock 79.2K Mar 23, 2022 The Tessier-Lavigne/Hynes Irrevocable Trust 2 F6
holding DNLI Common Stock 78.8K Mar 23, 2022 The Tessier-Lavigne/Hynes Irrevocable Trust 3 F7
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 For this amended Form 4 filing the only change is to add the signature.
F2 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $32.76 to $33.75 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F3 Includes 2,074 restricted stock units.
F4 The sale price reported in column 4 of Table I represents the weighted average sale price of the shares ranging from $33.76 to $34.69 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Reporting Person will provide full information regarding the number of shares sold at each separate price.
F5 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 1, for which the Reporting Person serves as trustee.
F6 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 2, for which the Reporting Person serves as trustee.
F7 The shares are held of record by The Tessier-Lavigne/Hynes Irrevocable Trust 3, for which the Reporting Person serves as trustee.